https://pipelinereview.com/sienna-biopharmaceuticals-announces-its-topical-non-steroidal-trka-inhibitor-sna-120-0-05-demonstrated-significant-impact-on-psoriasis-in-phase-2b-study-and-plans-to-initiate-phase-3-psoriasis-trials/